|
NicoDerm, also known as NicoDerm CQ (short for Committed Quit or Committed Quitter) is a branded over the counter nicotine replacement therapy used to minimize the withdrawal effects involved in quitting smoking. Other nicotine replacement therapy brand names include: Prostep, Habitrol, NiQuitin, Nicotrol, Nicorette, and Commit. ==History== NicoDerm is manufactured by ALZA Corporation, based in Mountain View, California. It is marketed by GlaxoSmithKline (GSK), Aventis and Pfizer. NicoDerm was approved by the FDA in 1991, as the first "nicotine transdermal system". It was the second product to provide an alternative to the withdrawal symptoms of quitting smoking. Nicotine gums, such as Pfizer's Nicotrol gum, were already available. For a time Nicotrol encompassed Pfizer's entire line of products, including gum, lozenges, inhalers and nasal sprays; the last two are still available, and the gum in New Zealand. Shortly after NicoDerm's initial release, the company added Clear NicoDerm, since some users had complained about the patch's inability to match a wide variety of skin colors. NicoDerm has become the most popular topical nicotine alternative. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Nicoderm」の詳細全文を読む スポンサード リンク
|